EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Accuracy and precision of few‐time‐points renal dosimetry for [ 177 Lu]Lu‐PSMA‐617 therapy: Analysis with nonlinear mixed‐effects modeling

Assyifa R Hakim, Deni Hardiansyah, Elham Yousefzadeh-Nowshahr, Ursula Nemer, Rien Ritawidya, Felix Kind, Ambros J Beer, Philipp T Meyer, Gerhard Glatting, Michael Mix

Medical Physics · 2026

DOI: 10.1002/mp.70212 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Physics, 2026. Verfasst von Assyifa R Hakim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical Physics and Biophysics, Physics Department, Faculty of Mathematics and Natural Sciences, Universitas Indonesia, Depok, Indonesia. Hauptthemen laut MEDLINE: Radiometry, Lutetium, Heterocyclic Compounds, 1-Ring, Dipeptides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitas Indonesia, DAAD, Degree by Research Scholarship Program-BRIN.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Determination of time‐integrated activity (TIA) with a reduced number of imaging sessions is essential for minimizing patient burden and clinical workload in the dosimetry of [ 177 Lu]Lu‐PSMA‐617. One approach to achieve this is by performing single‐time‐point (STP) dosimetry. However, STP dosimetry may be associated with significant accuracy errors in certain patients, potentially impacting the reliability of dose calculations. Moreover, the assessment of precision is crucial to evaluating the stability and reliability of estimated doses.

Purpose

This study aims to investigate the accuracy and precision of few‐time‐points (FTP) TIA calculation in kidneys for [ 177 Lu]Lu‐PSMA‐617 using nonlinear mixed‐effects modeling (NLMEM).

Methods

Biokinetic data of kidneys from 63 patients with metastatic castration‐resistant prostate cancer (mCRPC) treated with [ 177 Lu]Lu‐PSMA‐617 in the first treatment cycle were used. The SPECT/CT measurement was done at time points (TP) 1) (1.8 ± 0.8) h, 2) (18.7 ± 0.9) h, 3) (42.6 ± 1.0) h, 4) (66.3 ± 0.9) h, and 5) (160.3 ± 24.2) h after injection. This study used the sum‐of‐exponentials function (SOEF) with six parameters, previously selected as the best fit function for the biokinetic data (PMID: 38423787). Reference TIAs (rTIAs) were derived from fitting the SOEF parameters to all‐time‐points (ATP) data within the NLMEM framework. Estimated TIAs (eTIAs) were calculated by fitting the FTP data, which consist of one‐, two‐, three‐, and four‐time points combinations of the biokinetic data. The accuracy of FTP‐NLMEM TIA calculations was quantified using the root‐mean‐square error (RMSE) and mean absolute percentage error (MAPE) of the relative deviation between eTIAs and rTIAs. Precision was assessed from the coefficient of variation (CV) of individual TIA estimates at each optimal time‐point combination.

Results

For each optimal TP combination, the RMSEs and MAPEs were (11.0 ± 2.5)% and (7.0 ± 2.3)% for TP3, (6.3 ± 1.6)% and (4.8 ± 1.3)% for TP25, (3.9 ± 1.1)% and (2.3 ± 1.0)% for TP135, and (1.4 ± 0.8)% and (0.9 ± 0.8)% for TP1235. The %CV values of individual TIAs for each best TP combination were (17.1 ± 4.9)% for TP3, (8.5 ± 2.4)% for TP25, (6.3 ± 0.9)% for TP135, (5.1 ± 0.6)% for TP1235, and (4.4 ± 0.3)% for ATP.

Conclusion

The accuracy and precision of various FTP schemes have been determined and can be used to decide on the number of measurements required. Our study showed that incorporating TP3 in FTP dosimetry could lead to a high accuracy and precision of calculated individual TIAs in [ 177 Lu]Lu‐PSMA‐617therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RadiometryLutetiumHeterocyclic Compounds, 1-RingDipeptidesKidneyNonlinear DynamicsHumansMaleTime FactorsRadioisotopesProstatic Neoplasms, Castration-ResistantReproducibility of ResultsProstate-Specific Antigen

Stichwörter der Autor:innen

FTP dosimetryNLMEM[177Lu]Lu‐PSMA‐617 therapy

Substanzen

LutetiumHeterocyclic Compounds, 1-RingDipeptidesLutetium-177RadioisotopesPSMA-617Prostate-Specific Antigen

Autor:innen und Institutionen

  • Medical Physics and Biophysics, Physics Department, Faculty of Mathematics and Natural Sciences, Universitas Indonesia, Depok, Indonesia.
  • Medical Radiation Physics, Department of Nuclear Medicine, Ulm University, Ulm, Germany.
  • Department of Nuclear Medicine, Ulm University, Ulm, Germany.
  • Department of Nuclear Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Research Center for Radioisotope, Radiopharmaceutical, and Biodosimetry Technology, National Research and Innovation Agency (BRIN), Tangerang Selatan, Indonesia.

Förderung

  • Universitas Indonesia
  • DAAD
  • Degree by Research Scholarship Program-BRIN
  • Deutscher Akademischer Austauschdienst

Zitieren

APA

Hakim, A. R., Hardiansyah, D., Yousefzadeh-Nowshahr, E., Nemer, U., Ritawidya, R., Kind, F., Beer, A. J., Meyer, P. T., Glatting, G., & Mix, M. (2026). Accuracy and precision of few‐time‐points renal dosimetry for [ 177 Lu]Lu‐PSMA‐617 therapy: Analysis with nonlinear mixed‐effects modeling. Medical Physics. https://doi.org/10.1002/mp.70212

Vancouver

Hakim AR, Hardiansyah D, Yousefzadeh-Nowshahr E, Nemer U, Ritawidya R, Kind F, et al. Accuracy and precision of few‐time‐points renal dosimetry for [ 177 Lu]Lu‐PSMA‐617 therapy: Analysis with nonlinear mixed‐effects modeling. Medical Physics. 2026. doi:10.1002/mp.70212

BibTeX
@article{Hakim2026,
  author = {Hakim, Assyifa R and Hardiansyah, Deni and Yousefzadeh-Nowshahr, Elham and Nemer, Ursula and Ritawidya, Rien and Kind, Felix and Beer, Ambros J and Meyer, Philipp T and Glatting, Gerhard and Mix, Michael},
  title = {Accuracy and precision of few‐time‐points renal dosimetry for [ 177 Lu]Lu‐PSMA‐617 therapy: Analysis with nonlinear mixed‐effects modeling},
  journal = {Medical Physics},
  year = {2026},
  doi = {10.1002/mp.70212}
}
Kostenlos starten →